English
The pharma industry has been in a real economic and financial boom for 20 years, which is supported by recent technical developments, biotechnological research-innovation and deepening research on DNA and every microcell in the human body. An important part of this development is due to the IT industry, which has made available to pharma both the vast field of rapid global communication, as well as equipment and new technologies, in which artificial intelligence is starting to play an increasingly important role.
The competition in the pharma industry is fierce globally and in order to maintain or rather increase their competitiveness, companies in the field are forced to dig deep into their pockets to purchase state-of-the-art equipment and techniques. But to do this, the pharma giants need considerable revenue, and much of that comes from bringing to market innovative drugs, vaccines, and treatments designed to treat any real disease...or imagined.
25 years ago, with the development of the IT field, companies that sell solutions to protect devices and storage capacities against cyber attacks and so-called viruses began to rise rapidly. In order to sell an IT protection solution, cyber security firms simultaneously create the virus that the antivirus program is supposed to block or annihilate along with the proposed solution. Later after the simultaneous market release of the two, the companies create program upgrades aimed at combating other cyber virus variants, which of course they study at the same time as the upgrade solutions.
It seems that this method has also been taken over by the giants of the pharma industry, who over the last 20 years have launched several drugs, vaccines and treatments for various diseases that were not yet on the market or that, at the very least, appeared in market exactly with the treatment solution offered by the respective companies. An important role in this whole equation is played by the marketing industry, which in many cases promoted the existence of a disease that no one had heard of before - see the case of fibromyalgia and especially some mental illnesses, etc., defining in the respective campaigns the symptoms of such of diseases and presenting the innovative treatment solutions of some big companies.
Experts in the field talk about imaginary diseases or fake diseases, created by consistent paid marketing by the giants of the pharma industry to sell their innovative products. If we don't know about a disease, that doesn't mean it doesn't exist, but that it hasn't been invented and put on the market yet.
There is no evidence so far that the disease and the cure were created at the same time, but it seems that there is only one step missing.
What happened with Sars-Cov 2 and the Covid pandemic confirms the above. The pharma giants were studying an antiviral based on messenger RNA that would combat the Spike protein, but at the time of the outbreak of the pandemic, the product was not yet ready, although the disease was being studied in the laboratory in Wuhan, China. A security incident reportedly led to Sars-Cov 2 escaping from the lab nearly 10 months before Pfizer's vaccine received emergency FDA approval without being properly tested on as many human subjects as possible to know before launching it on the market what are the adverse reactions.
Some think that the pharma giants do not take anything into account, because revenues matter, and given that in just 4 years these revenues have increased by 60% (from 1 trillion dollars in 2019 to 1.6 trillion dollars at the end of 2023), they have the impression that everything is allowed to them.
• Gheorghe Piperea: "The Simultaneous Emergence of New Diseases and New Vaccines and Medicines - Proof That the Pharma Industry Is Involved in Turning Citizens into Mere Patients"
The appearance of new diseases alongside the emergence of new vaccines and medicines is proof that the pharma industry is involved in turning citizens into mere patients, argues European MP Gheorghe Piperea, a lawyer and university professor at the Faculty of Law at the University of Bucharest.
Gheorghe Piperea stated: "This is the harsh reality, and with each passing day, more evidence emerges that this is happening. I add two elements to this reality. One is that Bill Gates is the link between the IT sector and the pharma industry; he is the one who learned how to create viruses in order to already have the antivirus solutions ready, and he recently mentioned nightmares involving the intuition that we won't be able to avoid a world war, and therefore, we should expect another pandemic."
• Adrian Marinescu: "Discussions about the Laboratory Creation of Sars-Cov-2 and the Immediate Emergence of Covid Vaccines - Mere Speculations"
What happened in Wuhan was an accident, but it can be seen as a warning about what the pharma industry might prepare for us if global political leaders do not understand the need to regulate the industry more strictly.
Discussions about the laboratory creation of Sars-Cov-2, which led to the Covid-19 pandemic, and the immediate appearance of Covid vaccines are mere speculations, stated Dr. Adrian Marinescu, an epidemiologist and the medical director of the National Institute of Infectious Diseases "Prof. Dr. Matei Balş" in Bucharest.
Adrian Marinescu explained: "When referring to viral infections, we are talking about families of viruses that have always existed. For example, coronaviruses have always been present, causing infections in both humans and animals. Mutations are a permanent process because all viruses mutate. The public discussions regarding so-called artificial, laboratory mutations are a type of debate that could be called tabloid talk. Without specific information in this direction, we can only speculate. From a scientific perspective, mutations exist in every type of virus, and for a virus - such as Sars-Cov-2 - to become a public health issue, certain factors are needed to make it more contagious, because ultimately, the public health problem arises from the number of people who get infected."
Euro
Dolar SUA
Franc elveţian
Liră sterlină
Gram de aur
